Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of paclitaxel for the treatment of
gastric or gastroesophageal cancer. Drugs used in chemotherapy, such as paclitaxel, work in
different ways to stop the growth of tumor cells, either by killing the cells, by stopping
them from dividing, or by stopping them from spreading.